Phathom Pharmaceuticals

Voquezna Wins FDA Approval, GERD Game Changer

Phathom Triumphs with Dual FDA Nods for GERD Therapy Voquezna

3 November 2023

Anika Sharma

Phathom Pharmaceuticals has achieved rapid success with its innovative heartburn medication Voquezna (vonoprazan), securing two FDA approvals in just three ...

Phathom Pharmaceuticals, Erosive GERD, Vonoprazan, Complete Response Letter, Gastroesophageal reflux disease

Phathom Pharmaceuticals Boosts Erosive GERD Application with Six-Month Stability Data Submission for Vonoprazan

21 August 2023

Anika Sharma

Phathom Pharmaceuticals, a pioneering biopharmaceutical company dedicated to groundbreaking solutions for gastrointestinal ailments, has announced a significant stride in its ...